0.00Open0.00Pre Close0 Volume0 Open Interest12.50Strike Price0.00Turnover349.80%IV-305.84%PremiumJan 17, 2025Expiry Date9.42Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8606Delta0.0831Gamma0.32Leverage Ratio-0.0114Theta-0.0050Rho-0.28Eff Leverage0.0018Vega
Kazia Therapeutics Stock Discussion
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Wednesday, 11th December at 8:00 am
SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast Cancer Symposium ...
📊⚡️📊
Larger Image: tradingview.com...
$Kazia Therapeutics (KZIA.US)$
📊⚡️📊
📊⚡️📊
No comment yet